Cellulitis Completed Phase 2 Trials for Tedizolid phosphate (DB09042)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01519778A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA StudyOther